Trial Profile
Phase I Study of A Combination Stem Cell Therapy is Safe and Feasible in the Development of Mature Stable Vessels in Ischemic Limbs
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2014
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Peripheral ischaemia
- Focus Adverse reactions
- Sponsors TCA Cellular Therapy
- 15 Apr 2014 New trial record